Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tissue Plasminogen Activator”

304 trials

Showing 20 of 304 results

Not applicableStudy completedNCT06018181
What this trial is testing

Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice

Who this might be right for
Ischemic Stroke, Acute
Dongzhimen Hospital, Beijing 2,408
Testing effectiveness (Phase 2)Study completedNCT03340493
What this trial is testing

Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2)

Who this might be right for
Ischemic Stroke
Neuroscience Trials Australia 300
Not applicableLooking for participantsNCT06556446
What this trial is testing

Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

Who this might be right for
Ischemic Stroke
Insel Gruppe AG, University Hospital Bern 2,800
Testing effectiveness (Phase 2)WithdrawnNCT02956200
What this trial is testing

Combinating Fingolimod With Alteplase Bridging With Mechanical Thrombectomy in Acute Ischemic Stroke

Who this might be right for
StrokeInflammation
Second Affiliated Hospital, School of Medicine, Zhejiang University
Early research (Phase 1)Ended earlyNCT00004058
What this trial is testing

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Study completedNCT01240356
What this trial is testing

CLOTBUST Hands-Free: A Phase I/II Pilot Safety Trial

Who this might be right for
Stroke
The University of Texas Health Science Center, Houston 35
Early research (Phase 1)Ended earlyNCT01519076
What this trial is testing

A Safety Evaluation of the Use of Magnetic-guided Iron Particles

Who this might be right for
Ischemic Stroke
Pulse Therapeutics 7
Large-scale testing (Phase 3)Study completedNCT03151993
What this trial is testing

Single Bolus Recombinant Nonimmunogenic Staphylokinase (Fortelyzin) and Bolus Infusion Alteplase in Patients With AIS

Who this might be right for
Ischemic Stroke
Supergene, LLC 336
Not applicableStudy completedNCT06347107
What this trial is testing

Robotic Subretinal tPA Injection Study

Who this might be right for
Subretinal HemorrhageAge-Related Macular Degeneration
Universitaire Ziekenhuizen KU Leuven 20
Not applicableUnknownNCT05896618
What this trial is testing

Evaluation of Dental and Skeletal Effect of TPA and Nance as a Space Maintainers in Children: A Prospective Clinical Trial

Who this might be right for
Dental Malocclusion
Al-Azhar University 20
Post-approval studies (Phase 4)Study completedNCT00307580
What this trial is testing

Cathflo Activase Pediatric Study

Who this might be right for
Dysfunctional Central Venous Access Devices (CVADS)
Genentech, Inc. 300
Early research (Phase 1)Study completedNCT02216617
What this trial is testing

Evaluation of the Tolerance of Afatinib in Combination With Docetaxel and Cisplatin in LAHNSCC Induction Chemotherapy

Who this might be right for
HNSCC
Groupe Oncologie Radiotherapie Tete et Cou 8
Post-approval studies (Phase 4)Study completedNCT01073007
What this trial is testing

Stroke Treatment With Acute Reperfusion and Simvastatin

Who this might be right for
Stroke, Acute
Hospital Universitari Vall d'Hebron Research Institute 104
Not applicableStudy completedNCT03578107
What this trial is testing

Improve Acute Reperfusion Treatment Quality for Stroke in China, IMPROVE: Stroke Care in China

Who this might be right for
Ischemic Stroke
Beijing Tiantan Hospital 15,895
Not applicableStudy completedNCT04926428
What this trial is testing

In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection

Who this might be right for
COVID-19
Grupo Mexicano para el Estudio de la Medicina Intensiva 15
Not applicableStudy completedNCT03803176
What this trial is testing

Tissue Plasminogen Activator & Plasminogen Activator Inhibitor Type-1 In Gingival Tissues Of Chronic Periodontitis

Who this might be right for
Chronic Periodontitis
Cairo University 30
Large-scale testing (Phase 3)WithdrawnNCT02180204
What this trial is testing

Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)

Who this might be right for
Ischemic Stroke
Reza Behrouz, DO
Testing effectiveness (Phase 2)UnknownNCT05188417
What this trial is testing

A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
GrandPharma (China) Co., Ltd. 266
Testing effectiveness (Phase 2)Study completedNCT02448069
What this trial is testing

Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke

Who this might be right for
StrokeCerebral Ischemia
The University of Texas Health Science Center, Houston 10
Not applicableLooking for participantsNCT07419997
What this trial is testing

A Multicenter, Retrospective, Observational Cohort Study on Intravenous Thrombolysis Beyond the Time Window for Acute Ischemic Stroke

Who this might be right for
Stroke
Xuanwu Hospital, Beijing 2,600
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation